🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How I treat iron overload in adult MDS ow.ly/Fg1z50UMfgV #hematologicdisorders #howitreat #myeloidneoplasia #redcellsironanderythropoiesis

His Highness Prince Karim Al-Hussaini, Aga Khan IV, 49th hereditary Imam of the Shia Ismaili Muslims and direct descendant of the Prophet Muhammad (peace be upon him), passed away peacefully in Lisbon on 4 February 2025, aged 88, surrounded by his family. Prince Karim Aga Khan

🎉 Out now in Blood Advances 🙌🏽 Our work from Princess Margaret Cancer Centre looking at PTCy in matched sibling donor allogeneic transplantation with an excellent commentary by my good friend Nico Gagelmann 👇🏽 #MedTwitter ashpublications.org/bloodadvances/…

Correspondence: Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman’s Disease nej.md/4grvh9s #Hematology

Fascinating case series of Monoclonal Gammopathy of Thrombotic Significance published in this week's NEJM ➡️Important clinical implications in workup of unexplained thrombosis (both arterial and venous, including at unusual sites) 🧵1/5 tinyurl.com/2vpx7kyb

On This Day Tessa Virtue and Scott Moir won ice dance gold at PyeongChang 2018, capped off by a stunning performance of their Moulin Rouge free dance. ❤️💃 Their fifth Olympic medal made them the most decorated figure skating Olympians ever.🥇

Try to stop the acute attack. Plant the seed. Not every cyclical Abdo pain is nothing. Average diagnostic delay is 15 years! ⁦CAEP⁩ ⁦Eddy Lang⁩ ⁦Keerat Grewal⁩

Haemophilia A and B are the most prevalent severe bleeding disorders. In a new Seminar, discover the latest treatment options and management strategies for haemophilia to enhance patient quality of life: hubs.li/Q038L-bH0

OK PubMed is down It's run by the NIH and the main way to search for academic papers. If this isn't a temporary thing , and is a Trump/Musk doing, academics around the world are royally screwed right now.

Patients with a prothrombotic clinical course often associated with thrombocytopenia may have a monoclonal paraprotein, even at low levels, that activates platelets by binding to platelet factor 4. Learn more in a Brief Report: nej.md/4gKmrUs #Hematology

Prince Karim Aga Khan IV - The Lancet thelancet.com/journals/lance…

Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT trial) nej.md/41YkRZK Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months nej.md/4iB6wcA #ACC25 | American College of Cardiology

In this How I Treat series are topics related to the World Health Organization and International Consensus Classification major disease categories of “Mastocytosis” and “Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions.” ow.ly/ozEX50VCOAM

Glofit+pola for relapsed Burkitt lymphoma NEJM Curious, to say the least! nejm.org/doi/full/10.10… Mark Roschewski

Great review by the heme team McMaster Health Sciences Bispecific antibody toxicities cmaj.ca/content/197/7/…

Distinct characteristics and social determinants in adult T-cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada buff.ly/rce6WqZ

An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators buff.ly/CESED9G

Review Article: The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy nej.md/455rPiJ #Genetics #Hematology

CONGRESS | #18ICML | PRESENTATION Neil L. Berinstein, Sunnybrook Health Sciences Centre shares results from the ongoing phase II BRAWM trial of 1L fixed duration acalabrutinib in combination with bendamustine and rituximab in patients with Waldenström’s macroglobulinemia (N = 63). Fixed duration

Impressive data in the challenging-to-treat Richter’s transformation population with Ven+R-CHOP with 50% PFS at 15 months #18ICML #lymsm